Repository logo
  • English
  • CatalĆ 
  • ČeÅ”tina
  • Deutsch
  • EspaƱol
  • FranƧais
  • GĆ idhlig
  • Italiano
  • LatvieÅ”u
  • Magyar
  • Nederlands
  • Polski
  • PortuguĆŖs
  • PortuguĆŖs do Brasil
  • Suomi
  • Svenska
  • TürkƧe
  • Tiįŗæng Việt
  • ŅšŠ°Š·Š°Ņ›
  • বাংলা
  • ą¤¹ą¤æą¤‚ą¤¦ą„€
  • Ελληνικά
  • YŠŗŃ€Š°Ń—ĢŠ½ŃŃŒŠŗŠ°
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
  • Communities & Collections
  • All of NRU
  • English
  • CatalĆ 
  • ČeÅ”tina
  • Deutsch
  • EspaƱol
  • FranƧais
  • GĆ idhlig
  • Italiano
  • LatvieÅ”u
  • Magyar
  • Nederlands
  • Polski
  • PortuguĆŖs
  • PortuguĆŖs do Brasil
  • Suomi
  • Svenska
  • TürkƧe
  • Tiįŗæng Việt
  • ŅšŠ°Š·Š°Ņ›
  • বাংলা
  • ą¤¹ą¤æą¤‚ą¤¦ą„€
  • Ελληνικά
  • YŠŗŃ€Š°Ń—ĢŠ½ŃŃŒŠŗŠ°
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Mugarura, Lincoln"

Now showing 1 - 1 of 1
Results Per Page
Sort Options
  • Loading...
    Thumbnail Image
    Item
    High Rate of HIV Resuppression After Viral Failure on First-line Antiretroviral Therapy in the Absence of Switch to Second-line Therapy
    (Clinical infectious diseases, 2014) Gupta, Ravindra K.; Goodall, Ruth L.; Kityo, Cissy; Munderi, Paula; Lyagoba, Fred; Mugarura, Lincoln; Kaleebu, Pontiano; Pillay, Deenan
    In a randomized comparison of nevirapine or abacavir with zidovudine plus lamivudine, routine viral load monitoring was not performed, yet 27% of individuals with viral failure at week 48 experienced resuppression by week 96 without switching. This supports World Health Organization recommendations that suspected viral failure should trigger adherence counseling and repeat measurement before a treatment switch is considered.

Research Dissemination Platform copyright Ā© 2002-2026 NRU

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback